Isolation and identification of mouse and human...

Details Isolation and identification of mouse and human... Isolation and identification of mouse and human...

2002-04-11

2008-11-11

Bertoglio, Valarie (Department: 1632)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C800S003000, C435S354000, C435S007210

Reexamination Certificate

active

07449567

ABSTRACT:
The present invention relates to transcription control elements derived from mouse and human genes associated with cytochrome expression, e.g., Cyp3A11 and CYP3A4, respectively. Isolated polynucleotides, expression cassettes, vectors, recombinant cells, and transgenic animals, may comprise such transcription control elements as described herein.

REFERENCES:
patent: 4997757 (1991-03-01), Schiestl
patent: 6432639 (2002-08-01), Lichter et al.
patent: 2002/0150915 (2002-10-01), Berkenstam et al.
patent: 1 206 906 (2002-05-01), None
patent: WO 99/61622 (1999-12-01), None
patent: WO 01/20025 (2001-03-01), None
patent: WO 01/20026 (2001-03-01), None
patent: WO 02/25270 (2001-03-01), None
patent: WO 02/008451 (2002-01-01), None
patent: WO 02/36784 (2002-05-01), None
patent: WO 02/083897 (2002-10-01), None
patent: WO 02/088305 (2002-11-01), None
Huang, 1998, PNAS, vol. 95, pp. 14669-14674.
Mullins, 1993, Hypertension, vol. 22, pp. 630-633.
Mullins, 1990, Nature, Fulminant hypertension in transgenic rats harbouring the mose Ren-2 gene, vol. 344, pp. 541-544.
Hammer, 1990, Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta-2m: An animal model of HLA-B27-associated human disorders, Cell, vol. 63, pp. 1099.
Mullins, 1989, Expression of the DBA/2J Ren-2 gene in the adrenal gland of transgenic mice, EMBO J. vol. 8, pp. 4065-4072.
Mullins, 1996, J. Clin. Invest., vol. 98, pp. S37-S40.
Eck, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 1996, McGraw-Hill, pp. 77-101.
Verma, 1997, Nature, vol. 389, pp. 239-242.
Romano, G. 2000, Stem Cells, vol. 18, pp. 19-39.
Genes V, Oxford University Press, 1994, editor Ben Lewin, pp. 860-864.
Zhang et al., High Levels of Foreign Gene Expression in Hepatocytes after Tail Vein Injections of Naked Plasmid DNA, Human Gene Therapy, 10:1735-1737, 1999.
Herrmann, J et al, 2004, Arch Virol, 149:1611-1617.
Goodwin et al., “The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module,”Molecular Pharmacology56:1329-1339, 1999.
Finta et al., “The human cytochrome P450 3A locus. Gene evolution by capture of downstram exons,”Gene260(1-2):13-23, 2000.
Gellner et al., “Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene,”Pharmacogenetics11(2):111-121, 2001.
Itoh et al., “Isolation of a promoter region in mouse cytochrome P450 3A (Cyp3A16) gene and its transcriptional control,”Biochim Biophys Acta1350(2):155-158, 1997.
Macgregor et al., “New molecular endpoints and methods for routine toxicity testing,”Fundamental and Applied Toxicology26:156-173, 1995.
Martinez et al., “Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy,”Br. J. Cancer87(6):681-686, 2002.
Quattrochi et al., “CYP3A regulation: from pharmacology to nuclear receptors,”Drug Metabolism and Disposition29(5):615-622, 2001.
Reid et al., “Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans,”Clin. Cancer Res.8(9):2952-2962, 2002.
Smith et al., “Molecular genetics of the human cytochrome P450 monooxygenase superfamily,”Xenobiotica28(12):1129-1165, 1998.
Toide et al., “Gene Structure of mouse Cyp3a11: evidence for an enhancer element within its 5' flanking sequences,”Arch Biochem. and Biophysics338:43-49, 1997.
Yanagimoto et al., “Mouse liver cytochrome P-450 (P-450IIIAMI): its cDNA cloning and inducibility by dexamethasone,”Biochim. Biophs. Acta1130(3):329-332, 1992.
Barwick, et al., “Trans-species Gene Transfer for Analysis of Glucocorticoid-Inducible Transcriptional Activation of Transiently Expressed Human CYP3A$ and Rabbit CYP3A6 in Primary Cultures of Adult Rat and Rabbit Hepatocytes,” Molecular Pharmacology 50:10-16 (1996).
Hashimoto, et al., “Gene Structure of CYP3A4, an Adult-specific Form of Cytochrome P450 in Human Livers, and Its Transcrptional Control,” Eur. J. Biochem 218:585-595 (1993).
Ogg, et al., “Development of an In Vitro Reporter Gene Assay to Assess Xenobiotic Induction of the Human CYP3A4 Gene,” Eur. J. Drug Metab. Pharmacokinet 22(4):311-313 (1997).
Zhang et al., “Differential Regulation of the Human CYP34A Promoter in Transgenic Mice and Rats,” Drug Metabolism and Disposition 32(2):163-167 (2004).

Affiliated with

Also associated with

Rating

Isolation and identification of mouse and human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isolation and identification of mouse and human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation and identification of mouse and human... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4032353